Nigeria’s pharmaceutical industry, a cornerstone of public health, faces a formidable challenge, which is the proliferation of counterfeit and substandard drugs otherwise known as “fake drugs.” This scourge not only undermines trust in the health system but poses grave risks to patients, often leading to treatment failures and, in extreme cases, death. With Nigeria occupying an unenviable position as the largest market for counterfeit…
Read the full article here